Bio-Rad Laboratories
(BIO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2004 | 12-2003 | 12-2002 | 12-2001 | 12-2000 | |
| Cash Flows From Operating Activities | |||||
| Accounts receivable | 1,087,946 | 1,020,135 | 858,121 | 787,179 | 707,046 |
| Accounts payable and accrued liabilities | -920,606 | -826,055 | -682,814 | -665,572 | -636,054 |
| Other Working Capital | 123,093 | 127,640 | 106,571 | 99,538 | 24,247 |
| Other Operating Activity | -167,340 | -194,080 | -176,120 | -121,607 | -70,992 |
| Operating Cash Flow | $123,093 | $127,640 | $105,758 | $99,538 | $24,247 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -83,156 | -89,865 | -1,394 | -70 | 469 |
| PPE Investments | -60,493 | -69,003 | -42,224 | -43,228 | -31,406 |
| Net Acquisitions | -39,208 | -16,375 | -8,568 | -4,650 | 34,118 |
| Purchase Sale Intangibles | -10,000 | N/A | N/A | N/A | N/A |
| Other Investing Activity | -3,461 | -14,998 | -2,270 | 410 | 6,115 |
| Investing Cash Flow | $-186,318 | $-190,241 | $-54,456 | $-47,538 | $9,296 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 200,000 | 249,335 | 44,025 | 74,250 | 438,487 |
| Debt Repayment | -1,781 | -132,012 | -133,517 | -97,209 | -473,278 |
| Common Stock Issued | 7,464 | 5,309 | 5,334 | 4,899 | 2,388 |
| Common Stock Repurchased | N/A | N/A | N/A | -261 | -378 |
| Other Financing Activity | -12,456 | -14,463 | 5,031 | -1,884 | -8,825 |
| Financing Cash Flow | $193,227 | $108,169 | $-79,127 | $-20,205 | $-41,606 |
| Exchange Rate Effect | 337 | -7,906 | 8,429 | 1,380 | 4,930 |
| Beginning Cash Position | 65,395 | 27,733 | 47,129 | 13,954 | 17,087 |
| End Cash Position | 195,734 | 65,395 | 27,733 | 47,129 | 13,954 |
| Net Cash Flow | $130,339 | $37,662 | $-19,396 | $33,175 | $-3,133 |
| Free Cash Flow | |||||
| Operating Cash Flow | 123,093 | 127,640 | 105,758 | 99,538 | 24,247 |
| Capital Expenditure | -60,493 | -69,003 | -42,224 | -43,228 | -31,406 |
| Free Cash Flow | 62,600 | 58,637 | 63,534 | 56,310 | -7,159 |